Orthopediatrics Corp (NASDAQ:KIDS) has received an average broker rating score of 1.00 (Strong Buy) from the four brokers that cover the company, Zacks Investment Research reports. Four equities research analysts have rated the stock with a strong buy recommendation.
Brokerages have set a 12 month consensus price target of $23.67 for the company, according to Zacks. Zacks has also assigned Orthopediatrics an industry rank of 106 out of 265 based on the ratings given to related companies.
Several equities research analysts recently commented on the stock. BTIG Research assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $24.00 price target on the stock. Stifel Nicolaus assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $23.00 price target on the stock. William Blair assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “outperform” rating on the stock. Finally, Piper Jaffray Companies assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “overweight” rating and a $24.00 price target on the stock.
Shares of Orthopediatrics (KIDS) opened at $19.19 on Tuesday. Orthopediatrics has a fifty-two week low of $17.03 and a fifty-two week high of $23.00. The company has a debt-to-equity ratio of -0.38, a quick ratio of 1.00 and a current ratio of 2.78.
In related news, Director Harold Ruf purchased 11,500 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The shares were purchased at an average cost of $13.00 per share, for a total transaction of $149,500.00. The purchase was disclosed in a document filed with the SEC, which is available through this link.
TRADEMARK VIOLATION WARNING: This piece was reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.truebluetribune.com/2018/01/02/analysts-set-23-67-target-price-for-orthopediatrics-corp-kids.html.
Orthopediatrics Company Profile
OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.